In Vitro Immunomodulation of a Whole Blood IFN-γ Release Assay Enhances T Cell Responses in Subjects with Latent Tuberculosis Infection
Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional...
Saved in:
Published in | PloS one Vol. 7; no. 10; p. e48027 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
29.10.2012
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
ISSN | 1932-6203 1932-6203 |
DOI | 10.1371/journal.pone.0048027 |
Cover
Abstract | Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity.
In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls.
In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells.
In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI. |
---|---|
AbstractList | Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. Methods In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. Results In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. Conclusions In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI. Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. Methods In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. Results In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. Conclusions In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI. Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity.In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls.In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells.In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI. Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI. Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity.BACKGROUNDActivation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity.In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls.METHODSIn vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls.In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells.RESULTSIn vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells.In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.CONCLUSIONSIn vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI. |
Author | Banaei, Niaz Suhosk, Megan M. Gaur, Rajiv L. |
AuthorAffiliation | 1 Department of Pathology, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America 2 Department of Medicine,Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America 3 Clinical Microbiology Laboratory, Stanford Hospital and Clinics, Palo Alto, California, United States of America Hopital Raymond Poincare - Universite Versailles St. Quentin, France |
AuthorAffiliation_xml | – name: Hopital Raymond Poincare - Universite Versailles St. Quentin, France – name: 2 Department of Medicine,Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America – name: 3 Clinical Microbiology Laboratory, Stanford Hospital and Clinics, Palo Alto, California, United States of America – name: 1 Department of Pathology, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America |
Author_xml | – sequence: 1 givenname: Rajiv L. surname: Gaur fullname: Gaur, Rajiv L. – sequence: 2 givenname: Megan M. surname: Suhosk fullname: Suhosk, Megan M. – sequence: 3 givenname: Niaz surname: Banaei fullname: Banaei, Niaz |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23144722$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UttuEzEQXaEieoE_QGCJl74k-L5eHiqVqIWVIpAgwKPl9XobR1472LtU_QP-h__gm3CaBLUV4mlGM2fOnBmd4-LAB2-K4jmCU0RK9HoVxuiVm65zeQohFRCXj4ojVBE84RiSgzv5YXGc0gpCRgTnT4pDTBClJcZHxc_ag692iAHUfT_60Id2dGqwwYPQAQW-LYMz4K0LoQX15YfJ71_gk3FGJQPOU1I34MIvldcmgQWYGedyN2VFKResB5_HZmX0kMC1HZZgrgbjB7AYGxP16EKyCdS-y4C87mnxuFMumWe7eFJ8ubxYzN5P5h_f1bPz-UQzzIeJVqViTHcaMy4qiFClm67TFRYVgazkjLW8UqJrWooo4VSIhmslKBK86XRXkpPi5ZZ3nQXI3ROTRARzxjGFKCPqLaINaiXX0fYq3sigrLwthHglVRysdkZConirOeQlw5QwKDSmDUM56USLqM5cZ7ttY9ObVuf7o3L3SO93vF3Kq_BDEioIrlgmON0RxPB9NGmQvU06P1p5E8asGzFUYViVG-irB9B_X_firqK_UvaWyIA3W4COIaVoOqntcOuILNA6iaDc-G9PLjf-kzv_5WH6YHjP_9-xPwe_4q0 |
CitedBy_id | crossref_primary_10_1164_rccm_201406_1041LE crossref_primary_10_1016_j_jim_2013_08_004 crossref_primary_10_1093_occmed_kqt105 crossref_primary_10_1128_JCM_02803_15 crossref_primary_10_1016_j_jim_2014_10_011 crossref_primary_10_1128_CMR_00034_13 crossref_primary_10_1016_j_diagmicrobio_2015_05_007 crossref_primary_10_1128_JCM_01627_13 crossref_primary_10_4161_hv_27657 |
Cites_doi | 10.1097/QAI.0b013e31820b07ab 10.1038/nature04444 10.1128/CMR.00046-08 10.1016/j.immuni.2010.10.002 10.4049/jimmunol.176.5.3019 10.1371/journal.pone.0008517 10.1073/pnas.0901720106 10.1038/jid.2009.151 10.1126/science.1183021 10.1056/NEJM199612263352602 10.1084/jem.20081779 10.1093/oxfordjournals.aje.a121593 10.1016/j.tube.2011.01.001 10.1038/ni1112 10.1073/pnas.1015153108 10.1038/nm.2001 10.1073/pnas.1934678100 10.1172/JCI57235 10.7326/0003-4819-146-5-200703060-00006 10.1074/jbc.M702690200 10.1016/j.chembiol.2005.10.013 10.1038/ni712 10.1111/j.1600-065X.2008.00630.x 10.1038/nm0895-815 10.1016/j.immuni.2007.03.009 10.1371/journal.pone.0022074 10.1093/cid/cir068 10.1053/srin.2001.29315 10.1128/CMR.00027-06 10.1084/jem.20091750 10.1097/INF.0b013e318214b915 10.1084/jem.20051782 10.1093/aje/152.3.247 10.1038/ni1449 10.1038/ni1010 10.1164/ajrccm.161.supplement_3.ats600 10.1001/archderm.134.1.25 10.1172/JCI38482 |
ContentType | Journal Article |
Copyright | 2012 Gaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2012 Gaur et al 2012 Gaur et al |
Copyright_xml | – notice: 2012 Gaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2012 Gaur et al 2012 Gaur et al |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0048027 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection Proquest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Engineering Research Database ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Agricultural Science Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Medicine Biology |
DocumentTitleAlternate | Immunomodulation of IGRA Enhances TB Response |
EISSN | 1932-6203 |
ExternalDocumentID | 1326562401 oai_doaj_org_article_03a6dc60675243508c24b51508f8d14c PMC3483295 2943743661 23144722 10_1371_journal_pone_0048027 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US California |
GeographicLocations_xml | – name: United States--US – name: California |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RIG RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY CGR CUY CVF ECM EIF NPM PV9 RZL 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 PUEGO 5PM - 02 AAPBV ABPTK ADACO B0M BBAFP KM |
ID | FETCH-LOGICAL-c526t-ca7a55cfc256890119cbffc92893057655d69a8fbd41436488b6ca84186bfcf73 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Sun Jun 05 00:11:04 EDT 2022 Wed Aug 27 01:32:33 EDT 2025 Thu Aug 21 14:13:11 EDT 2025 Fri Sep 05 07:27:16 EDT 2025 Fri Jul 25 10:10:38 EDT 2025 Thu Apr 03 06:53:43 EDT 2025 Tue Jul 01 02:04:46 EDT 2025 Thu Apr 24 23:13:02 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c526t-ca7a55cfc256890119cbffc92893057655d69a8fbd41436488b6ca84186bfcf73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: NB is a provisional patent holder on in vitro immunomodulation of IGRA. Conceived and designed the experiments: RLG MMS NB. Performed the experiments: RLG MMS NB. Analyzed the data: RLG MMS NB. Contributed reagents/materials/analysis tools: RLG MMS NB. Wrote the paper: RLG NB. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0048027 |
PMID | 23144722 |
PQID | 1326562401 |
PQPubID | 1436336 |
ParticipantIDs | plos_journals_1326562401 doaj_primary_oai_doaj_org_article_03a6dc60675243508c24b51508f8d14c pubmedcentral_primary_oai_pubmedcentral_nih_gov_3483295 proquest_miscellaneous_1151920975 proquest_journals_1326562401 pubmed_primary_23144722 crossref_citationtrail_10_1371_journal_pone_0048027 crossref_primary_10_1371_journal_pone_0048027 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-10-29 |
PublicationDateYYYYMMDD | 2012-10-29 |
PublicationDate_xml | – month: 10 year: 2012 text: 2012-10-29 day: 29 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2012 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | JH Fritz (ref35) 2007; 26 A Cattamanchi (ref13) 2011; 56 CA Kauffman (ref37) 2007; 20 MJ Newport (ref22) 1996; 335 M Gilleron (ref26) 2006; 13 (ref1) 2010 SM Blower (ref6) 1995; 1 A Bafica (ref29) 2005; 202 LJ Abu-Raddad (ref5) 2009; 106 M Schnare (ref21) 2001; 2 E Ishikawa (ref27) 2009; 206 (ref4) 2000; 161 FJ Barrat (ref32) 2008; 223 V Herrera (ref9) 2011; 52 L Edwards (ref30) 1998; 134 A Iwasaki (ref34) 2004; 5 DL Barber (ref40) 2006; 439 (ref8) 2000; 49 GH Mazurek (ref11) 2010; 59 S Machingaidze (ref12) 2011; 30 K Honda (ref20) 2003; 100 TH Mogensen (ref17) 2009; 22 RL Coffman (ref31) 2010; 33 C von Pirquet (ref7) 1907; 52 N Banaiee (ref24) 2006; 176 S Winer (ref39) 2009; 15 SJ Huang (ref23) 2009; 129 H Bruns (ref42) 2009; 119 E Doz (ref25) 2007; 282 F Coulombe (ref28) 2009; 206 A Iwasaki (ref18) 2010; 327 M Ruhwald (ref16) 2011; 91 K Hoebe (ref19) 2003; 4 GW Comstock (ref2) 1974; 99 G Vogt (ref41) 2011; 121 D Pappagianis (ref38) 2001; 16 T Parkinson (ref33) 2008; 10 T Lahey (ref36) 2011; 6 D Menzies (ref10) 2007; 146 KA Millington (ref15) 2011; 108 RN van Zyl-Smit (ref14) 2009; 4 SA Khader (ref43) 2007; 8 E Vynnycky (ref3) 2000; 152 10933272 - Am J Epidemiol. 2000 Aug 1;152(3):247-63 17339619 - Ann Intern Med. 2007 Mar 6;146(5):340-54 10881762 - MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51 15454922 - Nat Immunol. 2004 Oct;5(10):987-95 8960473 - N Engl J Med. 1996 Dec 26;335(26):1941-9 21459676 - Tuberculosis (Edinb). 2011 May;91(3):260-7 19581406 - J Exp Med. 2009 Aug 3;206(8):1709-16 21427627 - Pediatr Infect Dis J. 2011 Aug;30(8):694-700 19381021 - J Clin Invest. 2009 May;119(5):1167-77 17617634 - J Biol Chem. 2007 Sep 7;282(36):26014-25 21911939 - J Clin Invest. 2011 Oct;121(10):3889-901 19666590 - Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13980-5 21427227 - Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5730-5 17433730 - Immunity. 2007 Apr;26(4):445-59 10764341 - Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47 17351619 - Nat Immunol. 2007 Apr;8(4):369-77 18613842 - Immunol Rev. 2008 Jun;223:271-83 16493060 - J Immunol. 2006 Mar 1;176(5):3019-27 20008526 - J Exp Med. 2009 Dec 21;206(13):2879-88 9449906 - Arch Dermatol. 1998 Jan;134(1):25-30 20577159 - MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25 14625548 - Nat Immunol. 2003 Dec;4(12):1223-9 21460320 - Clin Infect Dis. 2011 Apr 15;52(8):1031-7 21239993 - J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8 21799772 - PLoS One. 2011;6(7):e22074 4810628 - Am J Epidemiol. 1974 Feb;99(2):131-8 16365150 - J Exp Med. 2005 Dec 19;202(12):1715-24 21029960 - Immunity. 2010 Oct 29;33(4):492-503 16382236 - Nature. 2006 Feb 9;439(7077):682-7 17223625 - Clin Microbiol Rev. 2007 Jan;20(1):115-32 19633657 - Nat Med. 2009 Aug;15(8):921-9 20075244 - Science. 2010 Jan 15;327(5963):291-5 16426970 - Chem Biol. 2006 Jan;13(1):39-47 19516264 - J Invest Dermatol. 2009 Nov;129(11):2676-85 7585186 - Nat Med. 1995 Aug;1(8):815-21 20041113 - PLoS One. 2009;4(12):e8517 18228178 - Curr Opin Mol Ther. 2008 Feb;10(1):21-31 11547333 - Nat Immunol. 2001 Oct;2(10):947-50 11740825 - Semin Respir Infect. 2001 Dec;16(4):242-50 12960379 - Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10872-7 19366914 - Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents |
References_xml | – volume: 56 start-page: 230 issue: (3) year: 2011 ident: ref13 article-title: Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: A systematic review and meta-analysis publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31820b07ab – volume: 439 start-page: 682 issue: (7077) year: 2006 ident: ref40 article-title: Restoring function in exhausted CD8 T cells during chronic viral infection publication-title: Nature doi: 10.1038/nature04444 – volume: 22 start-page: 240 issue: (2) year: 2009 ident: ref17 article-title: Pathogen recognition and inflammatory signaling in innate immune defenses publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00046-08 – volume: 33 start-page: 492 issue: (4) year: 2010 ident: ref31 article-title: Vaccine adjuvants: Putting innate immunity to work publication-title: Immunity doi: 10.1016/j.immuni.2010.10.002 – volume: 176 start-page: 3019 issue: (5) year: 2006 ident: ref24 article-title: Potent inhibition of macrophage responses to IFN-γ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2 publication-title: J Immunol doi: 10.4049/jimmunol.176.5.3019 – volume: 4 start-page: e8517 issue: (12) year: 2009 ident: ref14 article-title: Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: A systematic review publication-title: PLoS One doi: 10.1371/journal.pone.0008517 – volume: 106 start-page: 13980 issue: (33) year: 2009 ident: ref5 article-title: Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0901720106 – volume: 129 start-page: 2676 issue: (11) year: 2009 ident: ref23 article-title: Imiquimod enhances IFN-γ production and effector function of T cells infiltrating human squamous cell carcinomas of the skin publication-title: J Invest Dermatol doi: 10.1038/jid.2009.151 – volume: 49 start-page: 1 issue: (RR-6) year: 2000 ident: ref8 article-title: Targeted tuberculin testing and treatment of latent tuberculosis infection. american thoracic society publication-title: MMWR Recomm Rep – volume: 327 start-page: 291 issue: (5963) year: 2010 ident: ref18 article-title: Regulation of adaptive immunity by the innate immune system publication-title: Science doi: 10.1126/science.1183021 – volume: 59 start-page: 1 issue: (RR-5) year: 2010 ident: ref11 article-title: Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - united states, 2010 publication-title: MMWR Recomm Rep – volume: 335 start-page: 1941 issue: (26) year: 1996 ident: ref22 article-title: A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection publication-title: N Engl J Med doi: 10.1056/NEJM199612263352602 – volume: 206 start-page: 1709 issue: (8) year: 2009 ident: ref28 article-title: Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide publication-title: J Exp Med doi: 10.1084/jem.20081779 – volume: 99 start-page: 131 issue: (2) year: 1974 ident: ref2 article-title: The prognosis of a positive tuberculin reaction in childhood and adolescence publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a121593 – volume: 91 start-page: 260 issue: (3) year: 2011 ident: ref16 article-title: A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis publication-title: Tuberculosis doi: 10.1016/j.tube.2011.01.001 – volume: 5 start-page: 987 issue: (10) year: 2004 ident: ref34 article-title: Toll-like receptor control of the adaptive immune responses publication-title: Nat Immunol doi: 10.1038/ni1112 – volume: 108 start-page: 5730 issue: (14) year: 2011 ident: ref15 article-title: Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1015153108 – volume: 15 start-page: 921 issue: (8) year: 2009 ident: ref39 article-title: Normalization of obesity-associated insulin resistance through immunotherapy publication-title: Nat Med doi: 10.1038/nm.2001 – volume: 100 start-page: 10872 issue: (19) year: 2003 ident: ref20 article-title: Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1934678100 – volume: 10 start-page: 21 issue: (1) year: 2008 ident: ref33 article-title: The future of toll-like receptor therapeutics publication-title: Curr Opin Mol Ther – volume: 121 start-page: 3889 issue: (10) year: 2011 ident: ref41 article-title: In vitro differentiation of human macrophages with enhanced antimycobacterial activity publication-title: J Clin Invest doi: 10.1172/JCI57235 – volume: 146 start-page: 340 issue: (5) year: 2007 ident: ref10 article-title: Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research publication-title: Ann Intern Med doi: 10.7326/0003-4819-146-5-200703060-00006 – volume: 282 start-page: 26014 issue: (36) year: 2007 ident: ref25 article-title: Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan publication-title: J Biol Chem doi: 10.1074/jbc.M702690200 – volume: 13 start-page: 39 issue: (1) year: 2006 ident: ref26 article-title: The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2 publication-title: Chem Biol doi: 10.1016/j.chembiol.2005.10.013 – volume: 2 start-page: 947 issue: (10) year: 2001 ident: ref21 article-title: Toll-like receptors control activation of adaptive immune responses publication-title: Nat Immunol doi: 10.1038/ni712 – volume: 223 start-page: 271 year: 2008 ident: ref32 article-title: Development of TLR inhibitors for the treatment of autoimmune diseases publication-title: Immunol Rev doi: 10.1111/j.1600-065X.2008.00630.x – volume: 1 start-page: 815 issue: (8) year: 1995 ident: ref6 article-title: The intrinsic transmission dynamics of tuberculosis epidemics publication-title: Nat Med doi: 10.1038/nm0895-815 – volume: 26 start-page: 445 issue: (4) year: 2007 ident: ref35 article-title: Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity publication-title: Immunity doi: 10.1016/j.immuni.2007.03.009 – year: 2010 ident: ref1 article-title: Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response – volume: 6 start-page: e22074 issue: (7) year: 2011 ident: ref36 article-title: Polyantigenic interferon-gamma responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization publication-title: PLoS One doi: 10.1371/journal.pone.0022074 – volume: 52 start-page: 1031 issue: (8) year: 2011 ident: ref9 article-title: Clinical application and limitations of interferon-γ release assays for the diagnosis of latent tuberculosis infection publication-title: Clin Infect Dis doi: 10.1093/cid/cir068 – volume: 16 start-page: 242 issue: (4) year: 2001 ident: ref38 article-title: Serologic studies in coccidioidomycosis publication-title: Semin Respir Infect doi: 10.1053/srin.2001.29315 – volume: 20 start-page: 115 issue: (1) year: 2007 ident: ref37 article-title: Histoplasmosis: A clinical and laboratory update publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00027-06 – volume: 206 start-page: 2879 issue: (13) year: 2009 ident: ref27 article-title: Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin mincle publication-title: J Exp Med doi: 10.1084/jem.20091750 – volume: 30 start-page: 694 issue: (8) year: 2011 ident: ref12 article-title: The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: A systematic review and meta-analysis publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0b013e318214b915 – volume: 202 start-page: 1715 issue: (12) year: 2005 ident: ref29 article-title: TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis publication-title: J Exp Med doi: 10.1084/jem.20051782 – volume: 152 start-page: 247 issue: (3) year: 2000 ident: ref3 article-title: Lifetime risks, incubation period, and serial interval of tuberculosis publication-title: Am J Epidemiol doi: 10.1093/aje/152.3.247 – volume: 8 start-page: 369 issue: (4) year: 2007 ident: ref43 article-title: IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge publication-title: Nat Immunol doi: 10.1038/ni1449 – volume: 4 start-page: 1223 issue: (12) year: 2003 ident: ref19 article-title: Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by trif-dependent and trif-independent pathways publication-title: Nat Immunol doi: 10.1038/ni1010 – volume: 161 start-page: S221 year: 2000 ident: ref4 article-title: Targeted tuberculin testing and treatment of latent tuberculosis infection. this official statement of the american thoracic society was adopted by the ATS board of directors, july 1999. this is a joint statement of the american thoracic society (ATS) and the centers for disease control and prevention (CDC). this statement was endorsed by the council of the infectious diseases society of america. (IDSA), september 1999, and the sections of this statement publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.161.supplement_3.ats600 – volume: 52 start-page: 675 year: 1907 ident: ref7 article-title: Frequency of tuberculosis in childhood publication-title: J A M A – volume: 134 start-page: 25 issue: (1) year: 1998 ident: ref30 article-title: Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. human PapillomaVirus publication-title: Arch Dermatol doi: 10.1001/archderm.134.1.25 – volume: 119 start-page: 1167 issue: (5) year: 2009 ident: ref42 article-title: Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans publication-title: J Clin Invest doi: 10.1172/JCI38482 – reference: 7585186 - Nat Med. 1995 Aug;1(8):815-21 – reference: 19366914 - Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents – reference: 17433730 - Immunity. 2007 Apr;26(4):445-59 – reference: 21239993 - J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8 – reference: 10933272 - Am J Epidemiol. 2000 Aug 1;152(3):247-63 – reference: 8960473 - N Engl J Med. 1996 Dec 26;335(26):1941-9 – reference: 21427627 - Pediatr Infect Dis J. 2011 Aug;30(8):694-700 – reference: 21799772 - PLoS One. 2011;6(7):e22074 – reference: 21459676 - Tuberculosis (Edinb). 2011 May;91(3):260-7 – reference: 10881762 - MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51 – reference: 4810628 - Am J Epidemiol. 1974 Feb;99(2):131-8 – reference: 14625548 - Nat Immunol. 2003 Dec;4(12):1223-9 – reference: 17223625 - Clin Microbiol Rev. 2007 Jan;20(1):115-32 – reference: 19516264 - J Invest Dermatol. 2009 Nov;129(11):2676-85 – reference: 19581406 - J Exp Med. 2009 Aug 3;206(8):1709-16 – reference: 19381021 - J Clin Invest. 2009 May;119(5):1167-77 – reference: 19666590 - Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13980-5 – reference: 18613842 - Immunol Rev. 2008 Jun;223:271-83 – reference: 20577159 - MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25 – reference: 21460320 - Clin Infect Dis. 2011 Apr 15;52(8):1031-7 – reference: 11740825 - Semin Respir Infect. 2001 Dec;16(4):242-50 – reference: 21911939 - J Clin Invest. 2011 Oct;121(10):3889-901 – reference: 17351619 - Nat Immunol. 2007 Apr;8(4):369-77 – reference: 16426970 - Chem Biol. 2006 Jan;13(1):39-47 – reference: 11547333 - Nat Immunol. 2001 Oct;2(10):947-50 – reference: 12960379 - Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10872-7 – reference: 19633657 - Nat Med. 2009 Aug;15(8):921-9 – reference: 10764341 - Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47 – reference: 20041113 - PLoS One. 2009;4(12):e8517 – reference: 15454922 - Nat Immunol. 2004 Oct;5(10):987-95 – reference: 21427227 - Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5730-5 – reference: 17339619 - Ann Intern Med. 2007 Mar 6;146(5):340-54 – reference: 16365150 - J Exp Med. 2005 Dec 19;202(12):1715-24 – reference: 16382236 - Nature. 2006 Feb 9;439(7077):682-7 – reference: 9449906 - Arch Dermatol. 1998 Jan;134(1):25-30 – reference: 20008526 - J Exp Med. 2009 Dec 21;206(13):2879-88 – reference: 17617634 - J Biol Chem. 2007 Sep 7;282(36):26014-25 – reference: 20075244 - Science. 2010 Jan 15;327(5963):291-5 – reference: 21029960 - Immunity. 2010 Oct 29;33(4):492-503 – reference: 18228178 - Curr Opin Mol Ther. 2008 Feb;10(1):21-31 – reference: 16493060 - J Immunol. 2006 Mar 1;176(5):3019-27 |
SSID | ssj0053866 |
Score | 2.1215346 |
Snippet | Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine... Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as... Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as... |
SourceID | plos doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e48027 |
SubjectTerms | Adaptive immunity Adjuvants Adolescent Adult Aged Aminoquinolines - immunology Aminoquinolines - pharmacology Antigen-presenting cells Antigens Assaying Biology Blood Cell activation Costimulator Cytokines Epidemics Female Humans Imiquimod Immune response Immune system Immunity Immunomodulation Immunotherapy In vitro methods and tests Infections Infectious diseases Inflammation Innate immunity Interferon Interferon-gamma - blood Interferon-gamma - immunology Interferon-gamma Release Tests - methods Laboratories Latent Tuberculosis - blood Latent Tuberculosis - diagnosis Latent Tuberculosis - immunology Ligands Lipopolysaccharides Lipopolysaccharides - immunology Lipopolysaccharides - pharmacology Lymphocytes Lymphocytes T Male Medicine Middle Aged Mycobacterium tuberculosis Poly (I:C) Poly I-C - immunology Poly I-C - pharmacology Polyinosinic:polycytidylic acid Proteins Receptors Reproducibility of Results Sensitivity Sensitivity and Specificity Sensitivity enhancement Studies T-Lymphocytes - drug effects T-Lymphocytes - immunology T-Lymphocytes - metabolism Toll-like receptors Toll-Like Receptors - agonists Toll-Like Receptors - immunology Tuberculosis Viral infections Young Adult γ-Interferon |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQ5a-hLTISBzikzZ_t-Fiqrlokemql3iL_RY1UnGqTgHgD3of34JmYcbyrXVSpF66xN7E9M55vvONvCPmgipwrxmyat1akVQ0xq3YWeW9dyXQJ9hfInr9e8vPr6ssNu9ko9YU5YTM98Lxwx1mpuDUcgW0Brj2rTVFphizmbW3zyuDum8lsFUzNezBYMefxolwp8uMol6P73rujcI0aq8hsOKLA14_8pnf98BDW_DdlcsMHLZ6TZxE80pN50LvkifMvyG40z4F-jBzSn16SXxeefu_GZU87vADSf-ttrNNF-5Yq-gPL4tKQtU4vFpfpn98Uq6eAS6OAptVP6vytCi-9oni2D60hlxYedJ4Ok8bjm4HiKS6F98Jw6ThptzQTTK3DTnOOl39FrhdnV6fnaSy6kBpW8DE1SoDsTGsAC9V4L1Ua3bZGQmAGWwOIjlkuVd1qWwHU4mD_mhtVV3nNdWtaUb4mOx6WeY_QzMJ2IZ223JWVLoSUSgjhBATzshZaJ6RcSaAxkZEcC2PcNeFvNgGRybyuDcqtiXJLSLr-1f3MyPFI_88o3HVf5NMOD0DLmqhlzWNalpA9VI3VBwb4XAFIGOBQnpCDlbo83Px-3QyWiyJT3vUT9AGwJUF3BUvIm1m71oME1F0hjWdCxJbebc1iu8V3t4EdvKxw1dnb_zHtffIUAGKBvrqQB2RnXE7uEEDYqN8Fe_sLwVkyRg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3LbtQwFLWgSIgNouXRQIuMxAIWaScvO15VbdWhg2gXaArdRX6lHWlwhklmwR_wP_wH39R7Pc7QQRVsY-fl-zrXj3MJeSvThMmiMHFSGx7nJeSsyhrkvbVZoTKwP0_2fHbOTi_yj5fFZZhwa8O2yt4nekdtGo1z5PuQNQH0gPiTHMy-x1g1CldXQwmN--RBApEG9bwcfug9MdgyY-G4XMaT_SCdvVnj7J4_TI21ZG6FI8_ajyyn06a9C3H-vXHyViQaPiGPA4Skh0uZb5J71m2Rh2dhkXyLbAZ7bem7QCr9_in5OXL0y6SbN3SEJ0Kab40JhbtoU1NJv2KdXHqE29jpaHge__5FP0NEghhHQYLyBz1x19I_dEyP7XQKrX5zLVyYOAruB-dzWorTuvQT4FfX0fFC2blewF9OWjoKm77cM3IxPBkfn8ahCkOsi5R1sZYchKlrDeCoxIOqQqu61gIyNfAVIMvCMCHLWpkcsBcDh6CYlmWelEzVuubZc7LhYMS3CR0Y8B_CKsNslquUCyE555ZDdi9KrlREsl4YlQ4U5VgpY1r5dTcOqcpyiCsUYRVEGJF4dddsSdHxn_5HKOdVXyTY9hea-VUV7LUaZJIZzTCfSgFRDkqd5qpA8vy6NEmuI7KNWtK_oK3-6GdEdnrNubv5zaoZTBnXZ6SzzQL6APoS6UDwIiIvloq2-kiA4TnyekaEr6ng2l-st7jJtacLz3Ic9eLlvz_rFXkEWDDFsJyKHbLRzRd2F_BWp157o7oBEbcswQ priority: 102 providerName: ProQuest |
Title | In Vitro Immunomodulation of a Whole Blood IFN-γ Release Assay Enhances T Cell Responses in Subjects with Latent Tuberculosis Infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23144722 https://www.proquest.com/docview/1326562401 https://www.proquest.com/docview/1151920975 https://pubmed.ncbi.nlm.nih.gov/PMC3483295 https://doaj.org/article/03a6dc60675243508c24b51508f8d14c http://dx.doi.org/10.1371/journal.pone.0048027 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELb2ceGCWF4bWCojcYBDqsZJ7OSAEK1atoit0KqF3iLbcXYrhWRpUon9B_wf_ge_iRnXrSgqQlxyiJ2HPTOeb_z4hpAXkgVcxnHuB0Uu_CiBmFWZHHlvTRirEOzPkj1fTPj5LHo_j-cHZJOz1XVgsze0w3xSs2XZ_fb19g0Y_GubtUEEm4e6N3VluvaQNBOH5Bh8E8dw7CLariuAddvVS0QtPme90B2m-9tbdpyV5fRHDtSybvbh0T-3Vf7mp0b3yF0HMOnbtUackANT3ScnzoQb-tLxTL96QL6PK_pp0S5rOsZDIvWXOne5vGhdUEk_Y-pc2sed7XQ8mvg_f9BLcFLg9igIVd7SYXUt7UundGDKEkrtflu4sagojEg4xdNQnOmlHwDSVi2drpRZ6hU0bdHQsdsHVj0ks9FwOjj3XWIGX8eMt76WAuSrCw14KcGzq6lWRaFTCN5g-ADxxjlPZVKoPAI4xmGMUFzLJAoSrgpdiPAROaqgm08J7eUwpKRG5dyEkWIiTaUQwggI-NNEKOWRcCOBTDvWckyeUWZ2KU5A9LLu1wzlljm5ecTfPnWzZu34R_0-CndbFzm37Y16eZU5E856oeS55hhiMQCZvUSzSMXIp18keRBpj5yiamw-0MDnGKBlgEyBR8426rK_-Pm2GKwbl2xkZeoV1AFAlrJeKmKPPF5r1_YnAZlHSPXpEbGjdzut2C2pFteWQTyMsNfjJ__ZTU_JHcCLDF03S8_IUbtcmWeAyVrVIYdiLuCaDAK8jt51yHF_OPl42bGzHB1rhr8ADIk8tA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VIgEbRMujhgKDBBIs3MavGXuBEA2NYppkgVLozp2XaaRghzgR6h_wNWz4D76Je-1xaFAFq249E2c893XuzH0Q8lz4HhNRpF0v19wNY_BZpdFY99YEkQxA_upiz8MR6x-H70-ikw3yo82FwbDKVifWilqXCs_I98FrAugB9sd7M_vqYtcovF1tW2g0bHFkzr-By1a9Tt8BfV_4fu9w3O27tquAqyKfLVwlOCxO5QqMfYyJl4mSea4S8DyA92FtkWaJiHOpQ8ASDBhcMiXi0IuZzFXOA3jvNXI9DAKGUhR3VyEloDsYs-l5Aff2LTfszcrC7NXJ29i75oL5q7sEYFXVaVldhnD_DtS8YPl6d8htC1np24bHtsiGKbbJjaG9lN8mW1Y_VPSlLWL96i75nhb042QxL2mKGSjll1LbRmG0zKmgn7AvLz3AsHma9kbur5_0A1hAsKkUOEac08PiTNQvHdOumU5htA7mhQeTgoK6w_OjiuIxMh0AXi4WdLyUZq6W8JWTiqY2yKy4R46vhD73yWYBO75DaEeDvkqM1MwEofR5kgjOueFG-knMpXRI0BIjU7YkOnbmmGb1PR8H16jZ4gxJmFkSOsRd_WrWlAT5z_wDpPNqLhb0rh-U88-Z1Q9ZJxBMK4b-mw8IthMrP5QRFuvPY-2FyiE7yCXtH1TZH3lwyG7LOZcPP1sNg-rA-yBRmHIJcwDtJX4n4ZFDHjSMtlokwP4Q64g6hK-x4NpXrI8Uk7O6PHkQ4q5HD_-9rKfkZn88HGSDdHT0iNwCHOojJPCTXbK5mC_NY8B6C_mkFjBKTq9aon8D7qlpJQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VIlVcEC0_NRRYJJDg4CZe27v2ASGaNqppGyHUQm_u_plGCnaIE6G-Ae_DjYfgmZhx1qFBFZx69W6c9c7_7sw3hDyXLOAyjo0fFEb4UQIxq7IGcW9tGKsQ5K8Bez4a8P2T6N1pfLpCfra1MJhW2erERlGbSuMZeQeiJnA9wP4EncKlRbzf7b8Zf_WxgxTetLbtNOYscmAvvkH4Vr_OdoHWLxjr7x339n3XYcDXMeNTX0sBC9WFBsOfYBFmqlVR6BSiEJADWGdseCqTQpkI_AoOzK64lkkUJFwVuhAhvPcGuSlCIVC6kt4ivQT0COeuVC8UQcdxxva4Ku12U8iNfWwumcKmYwAirI6q-ipv9--kzUtWsH-H3HbuK30757d1smLLDbJ25C7oN8i60xU1fekArV_dJd-zkn4cTicVzbAapfpSGdc0jFYFlfQT9uilO5hCT7P-wP_1g34Aawj2lQL3yAu6V57L5qXHtGdHIxhtEnvhwbCkoPrwLKmmeKRMD8F3Lqf0eKbsRM_gK4c1zVzCWXmPnFwLfe6T1RJ2fJPQrgHdlVpluA0jxUSaSiGEFVaxNBFKeSRsiZFrB4-OXTpGeXPnJyBMmm9xjiTMHQk94i9-NZ7Dg_xn_g7SeTEXwb2bB9Xkc-50Rd4NJTeaYyzHwJvtJppFKkbg_iIxQaQ9solc0v5Bnf-RDY9stZxz9fCzxTCoEbwbkqWtZjAHPL-UdVMRe-TBnNEWi4QQIEJMUY-IJRZc-orlkXJ43kCVhxHuevzw38t6StZAlvPDbHDwiNwCl5Shd8DSLbI6nczsY3D7pupJI1-UnF23QP8GpeptWw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vitro+Immunomodulation+of+a+Whole+Blood+IFN-%CE%B3+Release+Assay+Enhances+T+Cell+Responses+in+Subjects+with+Latent+Tuberculosis+Infection&rft.jtitle=PloS+one&rft.au=Gaur%2C+Rajiv+L.&rft.au=Suhosk%2C+Megan+M.&rft.au=Banaei%2C+Niaz&rft.date=2012-10-29&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=7&rft.issue=10&rft.spage=e48027&rft_id=info:doi/10.1371%2Fjournal.pone.0048027&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0048027 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |